- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
2117
Companies with a Value score of at least 3, ordered by Value score
2,117 companies
Spectrum Pharmaceuticals
Market Cap: €209.9m
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.
NTR
€0.93
7D
0.5%
1Y
11.6%
Viatris
Market Cap: US$9.0b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
0A5V
US$7.55
7D
-2.4%
1Y
-32.8%
Hikma Pharmaceuticals
Market Cap: €4.0b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
H5P
€21.60
7D
-2.7%
1Y
0.9%
Trajan Group Holdings
Market Cap: AU$131.0m
Develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.81
7D
3.8%
1Y
-34.7%
Grand Pharmaceutical Group
Market Cap: HK$20.7b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$5.91
7D
-6.6%
1Y
44.1%
Amneal Pharmaceuticals
Market Cap: €2.2b
A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.
2DT
€5.85
7D
-5.6%
1Y
13.6%
Bayer
Market Cap: €19.8b
Operates as a life science company worldwide.
BAYN
€20.34
7D
1.2%
1Y
-22.9%
Otsuka Holdings
Market Cap: €3.5t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
OS1
€41.40
7D
-5.5%
1Y
8.4%
Royalty Pharma
Market Cap: €18.4b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPD
€27.12
7D
5.4%
1Y
2.9%
Grand Pharmaceutical Group
Market Cap: €20.7b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
MX6A
€0.65
7D
2.4%
1Y
37.1%
Viatris
Market Cap: €9.0b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VIA
€6.40
7D
-6.4%
1Y
-40.6%
Bayer
Market Cap: US$19.8b
Operates as a life science company worldwide.
BAYZ.F
US$22.88
7D
6.8%
1Y
-18.3%
Teva Pharmaceutical Industries
Market Cap: €15.4b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEV
€11.55
7D
-9.8%
1Y
-8.7%
Genus
Market Cap: UK£1.1b
Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.
GNS
UK£16.10
7D
-4.5%
1Y
-8.6%
Indivior
Market Cap: €857.1m
Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
2IVB
€7.75
7D
-1.3%
1Y
-57.7%
Viatris
Market Cap: US$9.0b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$7.54
7D
-0.9%
1Y
-33.4%
Sandoz Group
Market Cap: CHF 13.7b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
SDZ
CHF 31.70
7D
0.5%
1Y
12.6%
Vetoquinol
Market Cap: €892.2m
A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.
0O1O
€75.40
7D
0%
1Y
-22.3%
Avantor
Market Cap: US$10.4b
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
AVTR
US$15.22
7D
-0.07%
1Y
-38.4%
Sanofi
Market Cap: €109.7b
A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.
1SAN
€89.63
7D
-1.9%
1Y
2.7%
Regeneron Pharmaceuticals
Market Cap: €59.3b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
RGO
€487.00
7D
-6.1%
1Y
-43.1%
Viatris
Market Cap: €9.0b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VIA
€6.42
7D
-4.2%
1Y
-39.6%
Almirall
Market Cap: €2.0b
Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.
0O9B
€9.17
7D
0.8%
1Y
12.1%
Aspen Pharmacare Holdings
Market Cap: €66.5b
Manufactures and supplies specialty and branded pharmaceutical products worldwide.
LDZA
€6.90
7D
-1.4%
1Y
-35.5%
Regeneron Pharmaceuticals
Market Cap: €59.3b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
1REGN
€471.90
7D
-8.5%
1Y
-44.7%
Apeloa PharmaceuticalLtd
Market Cap: CN¥16.0b
Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally.
000739
CN¥13.79
7D
-0.4%
1Y
6.0%
Otsuka Holdings
Market Cap: JP¥3.5t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥6,835.00
7D
-4.6%
1Y
7.7%
Amphastar Pharmaceuticals
Market Cap: US$1.2b
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$24.16
7D
-3.4%
1Y
-40.8%
Bayer
Market Cap: €19.8b
Operates as a life science company worldwide.
1BAYN
€20.17
7D
4.1%
1Y
-24.5%
Sichuan Kelun Pharmaceutical
Market Cap: CN¥57.0b
Researches, develops, manufactures, distributes, and sells pharmaceutical products in China.
002422
CN¥35.68
7D
-3.1%
1Y
19.9%
Bayer
Market Cap: €19.8b
Operates as a life science company worldwide.
0P6S
€20.14
7D
-2.4%
1Y
-25.3%
WuXi AppTec
Market Cap: CN¥149.0b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥52.10
7D
-18.0%
1Y
21.5%
Merck
Market Cap: €199.2b
Operates as a healthcare company worldwide.
6MK
€70.00
7D
-5.9%
1Y
-40.6%
Euroapi
Market Cap: €227.2m
Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use.
940
€2.33
7D
-2.3%
1Y
-14.3%
Collegium Pharmaceutical
Market Cap: €828.1m
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
354
€22.00
7D
-9.1%
1Y
-34.1%
Hikma Pharmaceuticals
Market Cap: UK£4.0b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
HIK
UK£18.30
7D
2.0%
1Y
1.3%